NEWS RELEASES

Search all of our news releases here.

Try these: Jeff GalvinC. David PauzaHIVFDAAmerican Gene Technologies

American Gene Technologies® to Present at ROTH MKM 2023 Healthcare Opportunities Conference

Oct 11, 2023

Rockville, MD, October 11, 2023 — American Gene Technologies® (AGT™), a clinical-stage biotechnology company dedicated to improving human health through innovative gene and cell therapies, today announced that Jeff Galvin, Founder and Chief Executive Officer, will present at the ROTH MKM Healthcare Opportunities Conference held…

Read More

Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to Go Public Through Business Combination with 10X Capital Venture Acquisition Corp. III

Aug 10, 2023

Addimmune’s investigational cell therapy, AGT103-T, makes gene modifications to the patients’ immune cells (T cells) that harden those cells against HIV infection and depletion, thus allowing those cells to target and kill HIV instead of being “killed” by the virus.    Thirty-eight million people are living…

Read More

American Gene Technologies® Launches New Spinoff Company “Addimmune™” to Focus Exclusively on Development of HIV Cure

Jun 9, 2023

Addimmune will build upon the success of American Gene Technologies Phase 1 HIV clinical trial, accelerating the clinical development with dedicated investment and singular focus on HIV.   (Rockville, Maryland – June 9, 2023) American Gene Technologies (AGT™), a clinical-stage biotechnology company based in Rockville,…

Read More
The Cure Chronicles, an innovative video series launched by American Gene Technologies, is the winner of the third annual BioBuzz Media Award

American Gene Technologies® Video Series “The Cure Chronicles” Wins BioBuzz Media Award

Mar 29, 2023

The Groundbreaking Series Features Engaging Conversations with People Living with HIV, Advocates and Medical Experts Striving Toward the Shared Goal of Ending HIV   “The Cure Chronicles,” an innovative video series launched by Maryland biotechnology company, American Gene Technologies, is the winner of the third…

Read More
Jeff Galvin, CEO and founder of American Gene Technologies, a clinical-stage biotechnology company based in Rockville, Maryland, has been awarded the Life Sciences Voice Top Industry Leaders Award

American Gene Technologies® CEO Jeff Galvin Wins Life Sciences Voice Top Industry Leaders Award

Mar 1, 2023

American Gene™ founder recognized as one of the field’s most dynamic leaders. Jeff Galvin, CEO and founder of American Gene Technologies®, a clinical-stage biotechnology company based in Rockville, Maryland, has been awarded the Life Sciences Voice Top Industry Leaders Award. The award recognizes the most…

Read More
American Gene Technologies has recorded data that meets the primary and secondary endpoints of its AGT103-T Phase 1 trial

American Gene Technologies® Phase I HIV Gene Therapy Clinical Trial Data Published in Frontiers Journal Shows Success in Safety & Durability

Dec 22, 2022

American Gene™ Plans for Phase 2 Trial of AGT103-T American Gene Technologies®, a clinical-stage biotechnology company based in Rockville, Maryland, has recorded data that meets the primary and secondary endpoints of its AGT103-T Phase 1 trial. The Phase 1 trial demonstrated that AGT103-T – an…

Read More
American Gene Technologies, congratulates Dr. Marcus Conant and UCSF Medical Center’s Department of Dermatology for establishing The Marcus Conant, MD, Endowment for HIV Dermatology and LGBTQ Health

American Gene Technologies® Chief Medical Officer Honored by UCSF Endowment for HIV Dermatology and LGBTQ Health Research

Nov 1, 2022

Dr. Marcus Conant Named in UCSF’s Commitment to Pave Way for Next Generation of HIV Researchers American Gene Technologies, a clinical-stage biotechnology company based in Rockville, Maryland, congratulates Dr. Marcus Conant and the University of California San Francisco (UCSF) Medical Center’s Department of Dermatology for…

Read More
American Gene Technologies promoted Barry H. Wells, M.D. as head of business development

American Gene Technologies® Welcomes Barry H. Wells, M.D., as Head of Business Development

Sep 19, 2022

Dr. Wells’ promotion comes as the company’s HIV clinical trial progresses American Gene Technologies, a clinical-stage biotechnology company based in Rockville, Maryland, has promoted Barry H. Wells, M.D. as head of business development. Dr. Wells joined the company’s investor relations team in 2019.   “I…

Read More
American Gene Technologies has reached a turning point in its HIV cure clinical trial: it began withdrawing participants from their antiretroviral drugs earlier this month

American Gene Technologies® HIV Cure Clinical Trial Enters Critical Phase: Withdrawing Participants from Antiretrovirals

Jul 28, 2022

Beginning the analytic treatment interruption is a pivotal step to potentially demonstrating a gene therapy cure for HIV. American Gene Technologies, a clinical-stage biotechnology company, has reached a turning point in its HIV cure clinical trial: it began withdrawing participants from their antiretroviral drugs earlier…

Read More
American Gene Technologies, a clinical-stage biotechnology company, has appointed Jeff Boyle, PhD as chief science officer

American Gene Technologies® Appoints Dr. Jeff Boyle as Chief Science Officer

Jun 21, 2022

Dr. Boyle’s biotech and intellectual property expertise strengthen the team as the company proceeds to next phase of its HIV cure clinical trial American Gene Technologies, a clinical-stage biotechnology company, has appointed Jeff Boyle, PhD as chief science officer. Dr. Boyle comes to the post…

Read More

Subscribe to News Releases and News Updates

Subscribe to our news release and published article updates to be notified when we release new content!

Follow AGT on Social Media

AGT on Facebook

Let's show the power of community! Support AGT's CEO, Jeff Galvin, in his nomination for the BioHealth Capital Region Leadership Award – your vote could help fund a potential HIV cure. Vote today: loom.ly/_cK3paM (Vote daily!). Need a daily reminder to vote? Sign up here: loom.ly/seqm6CY ... See MoreSee Less
View on Facebook
Happy Valentine's Day from everyone at AGT!Gene therapy unlocks the potential for life-changing breakthroughs. This Valentine's Day, we celebrate the scientists, researchers, and patients whose love of discovery fuels this incredible field.#happyvalentinesday #genetherapy ... See MoreSee Less
View on Facebook
Help support our work on a potential cure for HIV! CEO Jeff Galvin (AGT) is up for the BioHealth Capital Region Leadership Award.Please vote here: loom.ly/fu9fegI(You can vote once per day!)Would you like a daily reminder to vote?Sign up here for daily emails: loom.ly/seqm6CY#leadership #award #vote ... See MoreSee Less
View on Facebook